You are here: Home » PTI Stories » National » News
Business Standard

Dr Reddy's to appeal US District Court's decision on sale of generic Suboxone film

Press Trust of India  |  New Delhi 

today said it will appeal the decision of the of regarding further sales and commercialisation of its and sublingual film in

"The company disagrees with the court's decision, and will vigorously appeal it," Dr Reddy's said in a BSE filing.

The company intends to appeal the decision made by the of in a preliminary injunction hearing with respect to further sales and commercialisation of its product in the US, it added.

The Hyderabad-based firm had announced the receipt of approval by one of its wholly owned subsidiaries from the (USFDA) on June 15, 2018, Dr Reddy's said.

The approval was for the company's and sublingual film in various strengths for the US market. It is the generic version of UK's Suboxone sublingual film.

The product is indicated for treatment of opioid dependence.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, July 14 2018. 16:40 IST